Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry

Azilsartan medoxomil (AZL-M), has been demonstrated to be more effective than the other sartans currently in use; however, there is insufficient information available comparing it with ACE-inhibitors. Therefore, we aimed to compare the efficacy, safety, and tolerability of AZL-M with that of ACE-inh...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC cardiovascular disorders 2016-03, Vol.16 (56), p.56-56, Article 56
Hauptverfasser:	Gitt, Anselm K, Bramlage, Peter, Potthoff, Sebastian A, Baumgart, Peter, Mahfoud, Felix, Buhck, Hartmut, Ehmen, Martina, Ouarrak, Taoufik, Senges, Jochen, Schmieder, Roland E
Format:	Artikel
Sprache:	eng
Schlagworte:	ACE inhibitors Adult Aged Angiotensin II Type 1 Receptor Blockers - adverse effects Angiotensin II Type 1 Receptor Blockers - therapeutic use Angiotensin-Converting Enzyme Inhibitors - adverse effects Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - adverse effects Antihypertensive Agents - therapeutic use Antihypertensive drugs Arterial Pressure - drug effects Benzimidazoles - adverse effects Benzimidazoles - therapeutic use Chi-Square Distribution Drug therapy Female Germany Health aspects Humans Hypertension Hypertension - diagnosis Hypertension - drug therapy Hypertension - physiopathology Influence Male Medication Adherence Middle Aged Multivariate Analysis Odds Ratio Oxadiazoles - adverse effects Oxadiazoles - therapeutic use Practice Guidelines as Topic Prospective Studies Registries Renin-Angiotensin System - drug effects Risk Factors Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!